Literature DB >> 11445476

Application of the Mitrofanoff principle for intermittent self-catheterization in quadriplegic patients.

O W Hakenberg1, J Ebermayer, A Manseck, M P Wirth.   

Abstract

OBJECTIVES: Patients with cervical spinal cord lesions have impaired hand function, which often prohibits clean intermittent self-catheterization (CIC), especially in female patients. Enabling these patients to perform CIC gives them control of their bladder management and can improve their quality of life considerably. We have used an appendicovesicostomy to provide easy access for CIC in such patients.
METHODS: Five patients (4 women, 1 man) with a mean age of 31 years (range 20 to 52) and a mean duration of the cervical cord lesion of 22 months (range 7 to 37) underwent appendicovesicostomy. Three patients were young victims of motor vehicle accidents, 1 patient had a progressive rheumatoid arthritic disorder, and 1 patient had a complex functional paraplegia syndrome and underwent bladder augmentation at the same time.
RESULTS: The surgical procedure with the creation of a catheterizable stoma in the right lower abdominal quadrant was successful in all cases but was complicated by mechanical ileus in the patient with simultaneous bladder augmentation. All patients learned to perform independent CIC with continuing anticholinergic medication. Stomal stenosis did not occur in any of the 5 patients, and urinary tract infections occurred once in 2 patients and repeatedly in 1 patient. Three of 5 patients have been enabled by independent bladder management to achieve occupational rehabilitation.
CONCLUSIONS: Appendicovesicostomy is a suitable procedure in patients with cervical spinal cord lesions who are otherwise unable to perform independent CIC. The creation of a catheterizable abdominal stoma enables these patients to gain independent control of their bladder management. However, caution in patient selection is advisable as probably the best results are achieved in highly motivated, younger patients with traumatic cervical cord lesions.

Entities:  

Mesh:

Year:  2001        PMID: 11445476     DOI: 10.1016/s0090-4295(01)00996-7

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  7 in total

1.  [Neuro-urological diagnosis and therapy of lower urinary tract dysfunction in patients with spinal cord injury : S2k Guideline of the German-Speaking Medical Society of Paraplegia (DMGP), AWMF register no. 179/001].

Authors:  R Böthig; B Domurath; A Kaufmann; J Bremer; W Vance; I Kurze
Journal:  Urologe A       Date:  2017-06       Impact factor: 0.639

Review 2.  [Devastated bladder outlet-suprapubic catheter vs. reconstruction].

Authors:  A Kocot
Journal:  Urologe A       Date:  2020-04       Impact factor: 0.639

3.  How many spinal cord injury patients can catheterize their own bladder? The epidemiology of upper extremity function as it affects bladder management.

Authors:  D V Zlatev; K Shem; C S Elliott
Journal:  Spinal Cord       Date:  2016-01-19       Impact factor: 2.772

4.  Outcomes of urinary diversion in children with spinal cord injuries.

Authors:  Lisa A Merenda; Theresa Duffy; Randal R Betz; Mary Jane Mulcahey; Gregory Dean; Michel Pontari
Journal:  J Spinal Cord Med       Date:  2007       Impact factor: 1.985

5.  Pilot evaluation of functional questionnaire for predicting ability of patients with tetraplegia to self-catheterize after continent diversion.

Authors:  Ardavan Akhavan; Karin Baker; Glenn M Cannon; Benjamin Davies; John A Horton; Steven G Docimo
Journal:  J Spinal Cord Med       Date:  2007       Impact factor: 1.985

Review 6.  The urological management of children with spinal cord injury.

Authors:  Jairam R Eswara; Miguel Castellan; Ricardo González; Nicolas Mendieta; Marc Cendron
Journal:  World J Urol       Date:  2018-08-13       Impact factor: 4.226

7.  Transvaginal closure of urinary bladder opening and Mitrofanoff technique in a neurologically impaired female with chronic indwelling catheter: a case presentation.

Authors:  Athanasios Zachariou; Minas Paschopoulos; Aris Kaltsas; Fotios Dimitriadis; Athanasios Zikopoulos; Charalampos Mamoulakis; Atsushi Takenaka; Nikolaos Sofikitis
Journal:  BMC Urol       Date:  2021-06-27       Impact factor: 2.090

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.